Ecto-enzymes: Physiology meets pathology

Journal of Leukocyte Biology

Volumn 67, Issue 3, 2000, Pages 285-311

  Goding, J W ^a  

^a ALFRED HOSPITAL   (Australia)

Author keywords

Ecto ADP ribosyltransferase; Ecto apyrase; Ecto ATPase; Ecto phosphodiesterase pyrophosphatase; Ectokinase; Ectopeptidase; Ectotratranspeptidase

Indexed keywords

5' NUCLEOTIDASE; ADENOSINE DIPHOSPHATE; ADENOSINE RECEPTOR; ADENOSINE TRIPHOSPHATASE; ADENOSINE TRIPHOSPHATE; ALKALINE PHOSPHATASE; AMINOPEPTIDASE; APYRASE; CD38 ANTIGEN; COMPLEMENTARY DNA; DIADENOSINE POLYPHOSPHATE; DIPEPTIDYL PEPTIDASE IV; GLUTAMYL AMINOPEPTIDASE; INORGANIC PYROPHOSPHATASE; MEMBRANE METALLOENDOPEPTIDASE; MEMBRANE PROTEIN; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; NUCLEOSIDE; NUCLEOTIDE; PEPTIDASE; PHOSPHODIESTERASE; PROTEIN KINASE; T LYMPHOCYTE ANTIGEN;

ANIMAL CELL; BONE DEVELOPMENT; CELL DIFFERENTIATION; CELL MOTILITY; ENZYME ACTIVATION; ENZYME ACTIVE SITE; ENZYME REGULATION; ENZYME STRUCTURE; GENETIC POLYMORPHISM; HUMAN; HUMAN CELL; IMMUNE DEFICIENCY; INSULIN RESISTANCE; METASTASIS; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; RAT; REVIEW; SIGNAL TRANSDUCTION; TISSUE DISTRIBUTION;

ANIMALIA;

EID: 0033816854     PISSN: 07415400     EISSN: None     Source Type: Journal    
DOI: 10.1002/jlb.67.3.285     Document Type: Review

References (212)

1. Cell-surface enzymes and lymphocyte functions
2. Hematopoietic differentiation antigens that are membrane-associated enzymes: Cutting is the key!
3. Ectoenzymes as sites of peptide regulation
4. Ecto-enzymes of lymphoid cells
5. What do ectoenzymes do?
6. What are ecto-enzymes?
7. Enzymes as structural elements of physiological mechanism
8. Purinergic signaling: Pathophysiological roles
9. Localization of antigiotensin converting enzyme by in vitro autoradiography in the rabbit brain
10. Mineralocorticoid action: Target tissue specificity is enzyme, not receptor, mediated
11. Disorders of aldosterone biosynthesis and action
12. Aldosterone action: New answers, new questions
13. Why are enzymes so big?
14. Cell-surface anchoring of proteins via glycosyl-phosphatidylinositol structures
15. 5' Nucleotidase: Molecular structure and functional aspects
16. Characterization of soluble vs. membrane bound human placental 5' nucleotidase
17. Identification and characterization of a soluble form of the plasma cell membrane glycoprotein PC-1 (5'-nucleotide phosphodiesterase)
18. Autotaxin is an exoenzyme possessing 5'-nucleotide phosphodiesterase/ATP pyrophosphatase and ATPase activities
19. An ecto-ATPase and an ecto-ATP diphosphohydrolase are expressed in rat brain
20. Two novel families of ectonucleotidases: Molecular structures, catalytic properties and a search for function
21. Immunoglobulin RNA rearrangements in B lymphocyte differentiation
22. Two mRNAs with different 3' ends encode membrane-bound and secreted forms of immunoglobulin μ chain
23. Distribution of phosphodiesterase I in hormal human tissues
24. Distribution of the murine plasma cell antigen PC-1 in non-lymphoid cells
25. Ecto-phosphodiesterase/pyrophosphatase of lymphocytes and nonlymphoid cells: Structure and function of the PC-1 family
26. Mutation in Npps in a mouse model of ossification of the posterior longitudinal ligament of the spine
27. Germline deletion of the nucleoside triphosphate pyrophosphohydrolase (NTPPPH) plasma cell membrane glycoprotein (PC-1) produces abnormal calcification of periarticular tissues
28. Targeted disruption of the c-src proto-onocogene leads to osteopetrosis in mice
29. Proposed nomenclature for two novel nucleotide hydrolyzing enzyme families expressed on the cell surface
30. Purification and properties of a mouse liver plasma-membrane glycoprotein hydrolyzing nucleotide pyrophosphate and phosphodiester bonds
31. Nucleotide pyrophosphatase, a sialoglycoprotein located at the hepatocyte surface
32. Nucleotide pyrophosphatase of rat liver. A comparative study on the enzymes solubilized and purified from plasma membrane and endoplasmic reticulum
33. Location of nucleotide pyrophosphatase and alkaline phosphodiesterase activities on the lymphocyte surface membrane
34. Surface alloantigens of plasma cells
35. Properties of the PC-1 molecule
36. Structure of the murine plasma cell alloantigen PC-1: Comparison with the receptor for transferrin
37. Murine plasma cell membrane antigen PC-1: Molecular cloning of cDNA and analysis of expression
38. Plasma cell membrane glycoprotein PC-1: Primary structure deduced from cDNA clones
39. Plasma cell membrane glycoprotein PC-1: cDNA cloning of the human molecule, amino acid sequence and chromosomal location
40. Identification of nucleotide pyrophosphatase and alkaline phosphodiesterase I activity associated with the mouse plasma cell differentiation antigen PC-1
41. Expression of nucleotide pyrophosphatase/alkaline phosphodiesterase I activities of PC-1, the murine plasma cell antigen
42. Amino acid sequence of the active site peptide of bovine intestinal 5'-nucleotide phosphodiesterase and identification of the active site residue as threonine
43. Murine plasma cell antigen PC-1 has a region homologous to the active site of bovine 5' phosphodiesterase I (EC 3.1.4.1)
44. cDNA cloning of the human tumor motility-stimulating protein, autotaxin, reveals a homology with phosphodiesterases
45. Molecular cloning, expression, and localization of a brain-specific phosphodiesterase I/nucleotide pyrophosphatase (PD-1α) from rat brain
46. Affinity purification and cDNA cloning of rat neural differentiation and tumor cell surface antigen gp130(RB13-6) reveals relationship to human and murine PC-1
47. Molecular cloning and chromosomal localization of PD-1b (PDNP3), a new member of the human phosphodiesterase I genes
48. Association of the human NPPS gene with ossification of the posterior longitudinal ligament of the spine (OPLL)
49. The plasma cell membrane glycoprotein, PC-1, is a threonine-specific protein kinase stimulated by acidic fibroblast growth factor
50. The major acidic fibroblast growth factor (aFGF)-stimulated phosphoprotein from bovine liver plasma membranes has aFGF-stimulated kinase, autoadenylylation, and alkaline nucleotide phosphodiesterase activities
51. Phosphorylation and nucleotide-dependent dephosphorylation of hepatic polypeptides related to the plasma cell differentiation antigen PC-1
52. Regulation of purified hepatic PC-1 (phosphodiesterase-I/nucleotide pyrophosphatase) by threonine auto(de)phosphorylation and by binding of acidic fibroblast growth factor
53. Autophosphorylation of PC-1 (alkaline phosphodiesterase I) and analysis of the active site
54. Threonine autophosphorylation and nucleotidylation of the hepatic membrane protein PC-1
55. Deletion of Gpi7, a yeast gene required for addition of a side chain to the glycosylphosphatidylinositol (GPI) core structure, affects GPI protein transport, remodeling, and cell wall integrity
56. Calcium binding and conformational response in EF-hand proteins
57. Divalent cations stabilize the conformation of plasma cell membrane glycoprotein PC-1 (alkaline phosphodiesterase I)
58. Genomic structure and promoter analysis of the ecto-phosphodiesterase I gene (PDNP3) expressed in glial cells
59. Integrin signaling
60. A conserved RGD (Arg-Gly-Asp) sequence in the transferrin receptor is required for binding to transferrin
61. Molecular cloning of transferrin receptor 2. A new member of the transferrin receptor-like family
62. Genetic variation among 129 substrains: Practical consequences
63. Genetic variation among 129 substrains and its importance for targeted mutagenesis in mice
64. Plasma cell antigen PC-1 and the transferrin receptor in mouse, rat and hamster: Serologic and biochemical analysis
65. The murine plasma cell antigen PC-1: Purification and partial amino acid sequence
66. High level expression of the plasma cell antigen PC.1 on the T cell subset expanding in MRL/MpJ-lpr/lpr mice: Detection with a xenogeneic monoclonal antibody and alloantisera
67. A polymorphism (K121Q) of the human glycoprotein PC-1 gene coding region is strongly associated with insulin resistance (in process citation)
68. Cloning, chromosomal localization, and tissue expression of autotaxin from human teratocarcinoma cells
69. Biochemical and molecular identification of distinct forms of alkaline phosphodiesterase I expressed on the apical and basolateral plasma membrane surfaces of rat hepatocytes
70. A causal link between nucleotide pyrophosphohydrolase overactivity and increased intracellular inorganic pyrophosphate (PPi) generation is demonstrated by transfection of cultured fibroblasts and osteoblasts with PC-1 (Plasma Cell Membrane Glycoprotein-1): Relevance to CPPD deposition disease
71. Differential mechanisms of PPi generation by plasma cell membrane glycoprotein (PC-1) and B10 in chondrocytes.1
72. Interleukin-1β suppresses transforming growth factor-induced inorganic pyrophosphate (PPi) production and expression of the PPi-generating enzyme PC-1 in human chondrocytes
73. Expression of the nucleoside triphosphate pyrophosphohydrolase PC-1 is induced by basic fibroblast growth factor (bFGF) and modulated by the activation of the protein kinase A and C pathways in osteoblast-like osteosarcoma cells
74. Matrix vesicle plasma cell membrane glycoprotein-1 regulates mineralization by murine osteoblastic MC3T3 cells
75. 2+ mobilization is strongly potentiated by a parathyroid hormone/cAMP-dependent protein kinase pathway independent of mitogen-activated protein kinase
76. Membrane glycoprotein PC-1 and insulin resistance
77. Causes of insulin resistance
78. Deconstructing type 2 diabetes
79. Membrane glycoprotein PC-1 and insulin resistance in non-insulin-dependent diabetes mellitus
80. Inhibition of insulin receptor phosphorylation by PC-1 is not mediated by the hydrolysis of adenosine triphosphate or the generation of adenosine
81. The inhibition of the insulin receptor by the receptor protein PC-1 is not specific and results from the hydrolysis of ATP
82. Expression of the putative inhibitor of the insulin receptor tyrosine kinase PC-1 in dermal fibroblasts from patients with syndromes of severe insulin resistance
83. No correlation of plasma cell 1 overexpression with insulin resistance in diabetic rats and 3T3-LI adipocytes
84. The hydrolytic activity of bovine adrenal medullary plasma membranes towards diadenosine polyphosphates is due to alkaline phosphodiesterase-1
85. Phosphodiesterase I, a novel adhesion molecule and/or cytokine involved in oligodendrocyte function
86. Stimulation of tumor cell motility linked to phosphodiesterase catalytic site of autotaxin
87. Adenosine receptor mediates motility in human melanoma cells
88. Characterization of rat hepatocyte plasma membrane domains by monoclonal antibodies
89. Polarized expression of proteins of the phosphodiesterase/ nucleotide pyrophosphatase family in epithelial cells
90. Molecular cloning and chromosomal assignment of the human brain-type phosphodiesterase I/nucleotide pyrophosphatase gene (PDNP2)
91. Detection of a biliary cell membrane glycoprotein in the serum of cholangiocarcinoma-bearing rats. Possible relevance to the membrane proteins used as tumor markers in humans
92. Biochemical characterization of human PC-1, an enzyme possessing alkaline phosphodiesterase I and nucleotide pyrophosphatase activities
93. A role for acidic residues in di-leucine motif-based targeting to the endocytic pathway
94. A di-hydrophobic leu-val motif regulates the basolateral localization of CD44 in polarized Madin-Darby canine kidney epithelial cells
95. N-glycans mediate the apical sorting of a GPI-anchored, raft-associated protein in Madin-Darby canine kidney cells
96. Prediction of the coding sequences of unidentified human genes. XII. The complete sequences of 100 new cDNA clones from brain which code for large proteins in vitro
97. Ecto-ATPases: Identities and functions
98. Expression, distribution, and biochemistry of human CD39. Role in activation-associated homotypic adhesion of lymphocytes
99. 2+)-apyrase
100. Complementary DNA cloning and sequencing of the chicken muscle ecto-ATPase. Homology with the lymphoid cell activation antigen CD39
101. Loss of ATP diphosphohydrolase following endothelial cell activation
102. Apyrase administration prolongs discordant xenograft survival
103. Targeted disruption of CD39/ATP diphosphohydrolase resuts in disordered hemostasis and thromboregulation
104. CD38: A new paradigm in lymphocyte activation and signal transduction
105. Formation and hydrolysis of cyclic ADP-ribose catalyzed by lymphocyte antigen CD38
106. Human CD38 is an authentic NAD(P)+ glycohydrolase
107. Human CD38 (ADP-ribosyl cyclase) is a counter-receptor of CD31, an Ig-superfamily member
108. Identification and characterization of an active soluble form of human CD38 in normal and pathological fluids
109. Co-ordinated regulation of CD38 and other nucleotide hydrolyzing ecto-enzymatic activities in human T-cells
110. Ecto-5'-nucleotidase can provide the total purine requirements of mitogen-stimulated human T cells and rapidly dividing human B lymphoblastoid cells
111. Mice deficient for the ecto-NAD+ glycohydrolase CD38 exhibit altered humoral immune responses
112. Human CD38, a glycoprotein in search of a function
113. Human CD38, a cell-surface protein with multiple functions
114. Molecular characterization of a family of NAD+-metabolizing ectoenzymes in mice and men: Endogenous relatives of ADP-ribosylating bacterial toxins
115. Endogenous relatives of ADP-ribosylating bacterial toxins in mice and men: Potential regulators of immune cell function
116. Poly (ADP-ribose) polymerase, nitric oxide and cell death
117. Expression of NAD glycohydrolase activity by rat mammary adenocarcinoma cells transformed with rat T cell alloantigen RT6.2
118. Cloning and characterization of a novel membrane-associated lymphocyte NAD:arginine ADP-ribosyltransferase
119. Mouse T cell membrane proteins Rt6-1 and Rt6-2 are arginine/protein mono(ADPribosyl)transferases and share secondary structure motifs with ADP-ribosylating bacterial toxins
120. Two novel human members of an emerging mammalian gene family related to mono-ADP-ribosylating bacterial toxins
121. Molecular characterization of mouse T-cell ecto-ADP-ribosyltransferase Rt6: Cloning of a second functional gene and identification of the Rt6 gene products
122. Regulation of cytotoxic T cells by ecto-nicotinamide adenine dinucleotide (NAD) correlates with cell surface GPI-anchored/arginine ADP-ribosyltransferase
123. Regulation of CTL by ecto-nicotinamide adenine dinucleotide (NAD) involves ADP-ribosylation of a p56(Ick)-associated protein
124. Putting it on and taking it off: Phosphoprotein phosphatase involvement in cell cycle regulation
125. Processing of ADP-ribosylated integrin alpha 7 in skeletal muscle myotubes
126. Uncovered: The family relationship of a T-cell-membrane protein and bacterial toxins
127. 'Natural' RT6-1 and RT6-2 'knock-out' mice
128. Expression in BALB/c and C57BL/6 mice of Rt6-1 and Rt6-2 ADP-ribosyltransferases that differ in enzymatic activity: C57BL/6 Rt6-1 is a natural transferase knockout
129. CD73 expression and fyn-dependent signaling on murine lymphocytes
130. SCID: The role of adenosine deaminase deficiency
131. Ecto-enzyme and signaling functions of lymphocyte CD73
132. Disruption of the adenosine deaminase gene causes hepatocellular impairment and perinatal lethality in mice
133. Adenosine-deaminase deficient mice die perinatally and exhibit liver-cell degeneration, atelectasis and small intestinal death
134. Metabolic and immunologic consequences of limited adenosine deaminase expression in mice
135. The generation of alloreactive cytotoxic T lymphocytes requires the expression of ecto-5'-nucleotidase activity
136. Signal transduction through decay-accelerating facor. Interaction of glycosyl-phosphatidylinositol anchor and protein tyrosine kinases p56(Ick) and p59(fyn)
137. The glycosyl phosphatidylinositol anchor is critical for Ly-6A/E-mediated T cell activation
138. A glycophospholipid anchor is required for Qa-2-mediated Tcell activation
139. GPI-microdomains: A role in signalling via immunoreceptors
140. Mammalian alkaline phosphatases
141. Perspectives in alkaline phosphatase research
142. Hypophosphatasia: Nature's window on alkaline phosphatase function in man
143. Phosphatidylinositol anchor of HeLa cell alkaline phosphatase
144. Conversion of human placental alkaline phosphatase from a high Mr form to a low Mr form during butanol extraction. An investigation of the role of endogenous phosphoinositidespecific phospholipases
145. Inorganic pyrophosphate-phosphohydrolytic activity associated with rat osseous plate alkaline phosphatase
146. A superfamily of metalloenzymes unifies phosphopentomutase and cofactor-independent phosphoglycerate mutatase with alkaline phosphatases and sulfatases
147. Biology of human alkaline phosphatases with special reference to cancer
148. Genetic complexity, structure, and characterization of highly active bovine intestinal alkaline phosphatase
149. Inhibition of endogenous tissue alkaline phosphatase with the use of alkaline phosphatase conjugates in immunohistochemistry
150. Inactivation of two mouse alkaline phosphatase genes and establishment of a model of infantile hypophosphatasia
151. Physiological activity of adenine compounds with special reference to their action upon the mammalian heart
152. The past, present and future of purine nucleotides as signalling molecules
153. The liberation of adenosine triphosphate on antidromic stimulation of sensory nerves
154. Cardiac nucleotides in hypoxia: Possible role in regulation of coronary blood flow
155. Purines and their roles in apoptosis
156. Adenosine receptors
157. Insight into adenosine receptor function using antisense and gene- knockout approaches
158. Adenosine: A mediator of the sleep-inducing effects of prolonged wakefulness
159. Adenosine, adenosine receptors and the actions of caffeine
160. Caffeine alters plasma adenosine levels
161. Aggressiveness, hypoalgesia and high blood pressure in mice lacking the adenosine A(2a) receptor
162. Knockouts anxious for new therapy
163. 7 receptor
164. ATP-induced killing of mycobacteria by human macrophages is mediated by purinergic P2Z (P2X7) receptors
165. Cell-mediated immunity: Dealing a direct blow to pathogens
166. CD26/dipeptidyl peptidase IV in context: the different roles of a multifunctional ectoenzyme in malignant transformation
167. ECM and cell surface proteolysis: Regulating cellular ecology
168. Neutral endopeptidase 24.11 loss in metastatic human prostate cancer contributes to androgen-independent progression
169. CD10/neutral endopeptidase 24.11 hydrolyzes bombesin-like peptides and regulates the growth of small cell carcinoma of the lung
170. Neutral endopeptidase modulation of septic shock
171. CD13 - Not just a marker in leukemia typing
172. The enigmatic role of glutamyl aminopeptidase (BP-1/6C3 antigen) in immune system development
173. BP-1/6C3 expression defines a differentiation stage of transformed pre-B cells and is not related to malignant potential
174. T and B cell development in BP-1/6C3/ aminopeptidase A-deficient mice
175. CD26, a surface protease involved in T cell activation
176. Direct evidence for binding of rat liver DPP IV to collagen in vitro
177. Dipeptidyl peptidase IV/CD26 on T cells: Analysis of an alternative T cell activation pathway
178. The structure and function of CD26 in T cell immune response
179. Role of dipeptidyl peptidase IV (DP IV) in intestinal and renal absorption of peptides
180. Enhancement of antigen-induced T cell proliferation by soluble CD26/dipeptidyl peptidase IV
181. T cell antigen receptor pathways: The tyrosine connection
182. Direct association of adenosine deaminase with a T cell activation antigen
183. Begulation of the receptor specificity and formation of the chemokine RANTES (regulated on activation, normal T cell expressed and secreted) by dipeptydyl peptidase IV (CD26)-mediated cleavage
184. CD26/dipeptidyl peptidase IV differentially regulates the chemotaxis of T cell and monocytes toward RANTES: Possible mechanism for the switch from innate to acquired immune response
185. Natural truncation of RANTES abolishes signaling through the CC chemokine receptors CCR1 and CCR3, impairs its chemotactic potency and generates a CC chemokine inhibitor
186. Deletion of the NH2-terminal residue converts Monocyte Chemotactic Protein I from an activator of basophil mediator release to an eosinophil chemoattractant
187. A role for dipeptidyl peptidase IV in suppressing the malignant phenotype of melanocytic cells
188. The glutathione status of cells
189. The ectoenzyme γ-glutamyl transpeptidase regulates antiproliferative effects of S-nitrosoglutathione on human T and B lymphocytes
190. Growth retardation and cysteine deficiency in gamma-glutamyl transpeptidase-deficient mice
191. Accelerated methylmercury elimination in gamma-glutamyl transpeptidase-deficient mice
192. A thousand and one protein kinases
193. The protein kinase family: Conserved features and deduced phylogeny of the catalytic domains
194. Ecto-protein kinases: Ecto-domain phosphorylation as a novel target for pharmacological manipulation?
195. Ecto-protein kinase activity on the external surface of neural cells
196. Phosphorylation of extracellular domains of T-lymphocyte surface proteins
197. Surface protein phosphorylation by ecto-protein kinase is required for the maintenance of hippocampal long-term potentiation
198. Ectodomain phosphorylation of beta-amyloid precursor protein at two distinct cellular locations
199. Activation of human platelets by protein kinase C antibody: Role for surface phosphorylation in homeostasis
200. Differential biological effects of K252 kinase inhibitors are related to membrane solubility but not to permeability
201. Induced release of cell surface protein kinase yields CK1- and CK2-like enzymes in tandem
202. When is a lipid kinase not a kipid kinase? When it is a protein kinase
203. Inhibition of the membrane protein PC-1 by commercial acidic fibroblast growth factor is due to a non-protein contaminant
204. Signalling via ATP in the nervous system
205. To understand function, study structure
206. Moonlighting proteins
207. T lymphocyte costimulation mediated by reorganization of membrane microdomains
208. The immunological synapse: A molecular machine controlling T cell activation